NV
NOVARTIS AG
NVSOwnership as of Q2 2026
Funds owning
5
Combined value
1.1B
Avg portfolio %
0.4%
Buys / Sells this quarter
+1 buys−5 sells
Q2-2026
| Investor | Weight | Q/Q change | Value |
|---|---|---|---|
TB Tweedy Browne Coas of Q1-2026 | Trial 0.87% | ↘Reduced 4.81% | 71.3K shares · $152.75 $10.9M |
D& Dodge & Coxas of Q1-2026 | Trial 0.59% | ↘Reduced 22.71% | 7.0M shares · $152.75 $1.1B |
KB Kahn Brothers Groupas of Q1-2026 | Trial 0.36% | ↘Reduced 2.13% | 13.4K shares · $152.75 $2.0M |
MC Maverick Capital – Lee Ainslieas of Q1-2026 | Trial 0.03% | ↗Added 37.70% | 15.2K shares · $152.75 $2.3M |
CC Causeway Capital Managementas of Q1-2026 | Trial 0.00% | ↘Reduced 23.15% | 1.5K shares · $152.77 $227,167 |
| 5 funds | $1.1B |